Nonetheless, factors that would be associated with diabetes duration—such as the extent of subclinical CVD and the presence of senescence and mobility disorders, e.g., frailty—did not explain the differences in mortality between those with or without DM and those treated and not treated with insulin. This evidence concerns the gene INS and diabetes mellitus.